MDWD,MediWound Ltd. | Healthcare

Healthcare

MDWD

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

MediWound Ltd.MDWD

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally.

It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.

The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma.

MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Latest News >

Transact Technologies Insider Bought Shares Worth $351,037, According to a Recent SEC Filing

Mar 17, 2026

04:37 PM EDT, 03/17/2026 (MT Newswires) -- John Dillon, Director, CEO, on March 13, 2026, executed a purchase for 100,000 shares in Transact Technologies ( TACT ) for $351,037. Following the Form 4 filing with the SEC, Dillon has control over a total of 268,318 common shares of the company, with 168,318 shares held directly and 100,000 controlled indirectly. SEC...

Energy Vault Q4 Swings to Adjusted Earnings, Revenue Rises; 2026 Guidance Set

Mar 17, 2026

04:40 PM EDT, 03/17/2026 (MT Newswires) -- Energy Vault ( NRGV ) reported Q4 adjusted earnings late Tuesday of $0.02 per diluted share, swinging from a loss of $0.17 a year earlier. Revenue for the three months ended Dec. 31 was $153.3 million, up from $33.5 million a year earlier. Three analysts surveyed by FactSet expected $148.4 million. For the...

Cibus Fiscal Q4 Loss Narrows, Revenue Lower

Mar 17, 2026

04:40 PM EDT, 03/17/2026 (MT Newswires) -- Cibus ( CBUS ) reported a fiscal Q4 net loss late Tuesday of $0.59 per diluted share, narrowing from a loss of $0.87 a year earlier. Analysts polled by FactSet expected a loss of $0.35. Revenue for the quarter ended Dec. 31 was $1.1 million, down from $1.2 million a year earlier. Analysts...

Equities Notch Back-to-Back Gains as Fed Policy Meeting Begins; Oil Prices Advance

Mar 17, 2026

04:39 PM EDT, 03/17/2026 (MT Newswires) -- US equities notched back-to-back gains on Tuesday as the Federal Reserve's two-day monetary policy meeting began, while sentiment remained on shaky ground as the Iran war dragged on. The Nasdaq Composite closed 0.5% higher at 22,479.5, while the S&P 500 gained 0.3% to settle at 6,716.1. The Dow Jones Industrial Average ticked up...